Co-Targeting of CD38 and CD47 in T Cell Acute Lymphoblastic Leukemia
Sign Up to like & getrecommendations! Published in 2020 at "Blood"
DOI: 10.1182/blood-2020-140270
Abstract: Antibody application is a promising therapy in hematological malignancies including acute lymphoblastic leukemia (ALL). Unlike for B-cell precursor (BCP-ALL), immunotherapeutic interventions in T-cell ALL (T-ALL) are practically non-existent. Most T-ALL patient samples show substantial surface… read more here.
Keywords: hu5f9 igg2; phagocytosis; cd47; dara ... See more keywords